Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized multicenter trial for the prevention of preterm delivery by testing for and treatment of bacterial vaginosis in the first trimester of pregnancy.

Next Previous
Trial Profile

Randomized multicenter trial for the prevention of preterm delivery by testing for and treatment of bacterial vaginosis in the first trimester of pregnancy.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Jun 2013

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Clindamycin (Primary)
  • Indications Bacterial infections; Bacterial vaginosis; Preterm birth
  • Focus Therapeutic Use
  • Acronyms PREMEVA

Most Recent Events

  • 05 Dec 2011 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
  • 05 Dec 2011 Trial acronym (PREMEVA) identified as reported by ClinicalTrials.gov.
  • 09 Apr 2008 New trial record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top